Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Monopar Therapeutics Inc (MNPR) Ownership Overview
16.92% Insiders
0.43% Mutual Funds
20.42% Other Institutional Investors
0.93% ETFs
61.29% Public Companies and
Individual Investors
The ownership structure of Monopar Therapeutics Inc (MNPR) stock is a mix of institutional, retail, and individual investors. Approximately 21.78% of the company’s stock is owned by Institutional Investors, 16.92% is owned by Insiders, and 61.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 16, 2025 | xxxxxxxxxxxxx | $356160 | |
Jul 16, 2025 | xxxxxxxxxxxxx | $672000 | |
Jul 16, 2025 | xxxxxxxxxxxxx | $672000 | |
Apr 04, 2025 | xxxxxxxxxxxxx | $1166690 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,086,257 | Insider | 50.02% | 168,170,144 | |
| 895,727 | Insider | 14.52% | 48,808,164 | |
| 822,255 | Insider | 13.33% | 44,804,675 | |
| 511,207 | Institution | 8.29% | 27,855,669 | |
| 146,624 | Institution | 2.38% | 7,989,542 | |
| 68,878 | Institution | 1.12% | 3,753,162 | |
| 56,644 | Institution | 0.92% | 3,086,532 | |
| 45,858 | Insider | 0.74% | 2,498,802 | |
| 40,964 | Institution | 0.66% | 2,232,128 | |
| 26,863 | Insider | 0.44% | 1,463,765 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 56,644 | Institution | 0.92% | 3,086,532 | |
| 40,964 | Institution | 0.66% | 2,232,128 | |
| 3,000 | Institution | 0.05% | 163,470 | |
| 2,749 | Institution | 0.04% | 149,793 | |
| 1,878 | Institution | 0.03% | 102,332 | |
| 1,195 | Institution | 0.02% | 65,116 | |
| 814 | Institution | 0.01% | 44,355 | |
| 383 | Institution | <0.01% | 20,870 | |
| 131 | Institution | <0.01% | 7,138 | |
| 21 | Institution | <0.01% | 1,144 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 99,770 | Institution | 1.62% | 5,436,467 | |
| 45,629 | Institution | 0.74% | 1,879,002 | |
| 37,477 | Institution | 0.61% | 2,042,122 | |
| 19,365 | Institution | 0.31% | 797,451 | |
| 9,581 | Institution | 0.16% | 522,069 | |
| 3,800 | Institution | 0.06% | 207,062 | |
| 3,608 | Institution | 0.06% | 148,577 | |
| 2,043 | Institution | 0.03% | 100,556 | |
| 459 | Institution | <0.01% | 22,613 | |
| 402 | Institution | <0.01% | 19,786 |
FAQ
Who Owns Monopar Therapeutics Inc (MNPR)?
According to the latest TipRanks data, approximately 20.42% of the company's stock is held by institutional investors, 16.92% is held by insiders, and 61.29% is held by retail investors.
What percentage of Monopar Therapeutics Inc (MNPR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.42% of Monopar Therapeutics Inc (MNPR) stock is held by institutional investors.
What percentage of Monopar Therapeutics Inc (MNPR) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.29% of Monopar Therapeutics Inc (MNPR) stock is held by retail investors.
Who owns the most shares of Monopar Therapeutics Inc (MNPR)?
Arthur Klausner owns the most shares of Monopar Therapeutics Inc (MNPR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.